Quick Answer
Entera Bio Ltd. reported Net Income Loss of -$11.44 million for the year ending 2025.
- Entera Bio Ltd. showed a decrease of -19.9% in Net Income Loss from 2024 to 2025.
- This data is from Entera Bio Ltd.'s annual report (Form 10-K), filed with the SEC on March 27, 2026.
- XBRL data for this metric is available from 2020 to 2025 (6 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 6 years of available data (2020 to 2025), Entera Bio Ltd.'s Net Income Loss has declined by 2.0%.
- Historical annual values: Fiscal year 2025: -$11.44 million | Fiscal year 2024: -$9.54 million | Fiscal year 2023: -$8.89 million | Fiscal year 2022: -$13.07 million | Fiscal year 2021: -$12.19 million | Fiscal year 2020: -$11.22 million.
- Data sourced from SEC EDGAR public filings as of June 20, 2026.
Last verified: